TABLE 15

Results of regression analyses for costs and QALYs: subgroup analysis by injury type

Ιnjury typeCoefficient95% CIp-valueMarginal effect
Blunt (n = 1014) Total cost of hospital stay
Intervention arm0.0150.089 to 0.1190.779308
Total cost for blood products
Intervention arm0.1780.034 to 0.3220.015325
Total cost
Intervention arm0.028−0.067 to 0.1230.560633
QALYs (without imputation) a
Intervention arm0.006−0.001 to 0.0020.498
QALYs (with imputation)
Intervention arm0.003−0.001 to 0.0020.676
Penetrating (n = 567) Total cost of hospital stay
Intervention arm−0.075−0.116 to 0.0980.866−874
Total cost for blood products
Intervention arm0.4370.254 to 0.620< 0.01857
Total cost
Intervention arm−0.001−0.168 to 0.1660.988−17
QALYs (without imputation) b
Intervention arm−0.003−0.006 to 0.0000.082
QALYs (with imputation)
Intervention arm−0.003−0.005 to −0.0010.023
a

n = 726.

b

n = 335.

From: Chapter 4, Economic evaluation

Cover of Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis
Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis.
Health Technology Assessment, No. 28.76.
Curry N, Davenport R, Thomas H, et al.
Copyright © 2024 Curry et al.

This work was produced by Curry et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.